DHMYX
Price
$26.70
Change
-$0.29 (-1.07%)
Updated
Dec 17 closing price
MVCAX
Price
$31.32
Change
-$0.33 (-1.04%)
Updated
Dec 17 closing price
Ad is loading...

DHMYX vs MVCAX

Header iconDHMYX vs MVCAX Comparison
Open Charts DHMYX vs MVCAXBanner chart's image
Diamond Hill Small-Mid Cap Y
Price$26.70
Change-$0.29 (-1.07%)
VolumeN/A
CapitalizationN/A
MFS Mid Cap Value A
Price$31.32
Change-$0.33 (-1.04%)
VolumeN/A
CapitalizationN/A
DHMYX vs MVCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHMYX vs. MVCAX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHMYX is a Sell and MVCAX is a Hold.

FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.7B vs. DHMYX (1.23B). DHMYX pays higher dividends than MVCAX: DHMYX (1.27) vs MVCAX (1.16). DHMYX was incepted earlier than MVCAX: DHMYX (13 years) vs MVCAX (23 years). MVCAX is a more actively managed with annual turnover of: 19.00 vs. DHMYX (16.00). MVCAX has a lower initial minimum investment than DHMYX: MVCAX (1000) vs DHMYX (500000). MVCAX annual gain was more profitable for investors over the last year : 7.20 vs. DHMYX (5.97). MVCAX return over 5 years is better than : 32.46 vs. DHMYX (21.73).
DHMYXMVCAXDHMYX / MVCAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD4.5015.87277%
Front LoadN/AN/A-
Min. Initial Investment500000100050,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.23B17.7B7%
Annual Yield % from dividends1.271.16109%
Returns for 1 year5.977.2083%
Returns for 3 years0.085.741%
Returns for 5 years21.7332.4667%
Returns for 10 years55.0968.2581%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HSAI13.923.72
+36.47%
Hesai Group American Depositary Share each ADS represents one
DNUT9.730.03
+0.31%
Krispy Kreme
GTBP2.49-0.02
-0.80%
GT Biopharma
RRX162.51-3.39
-2.04%
Regal Rexnord Corp
GALT2.12-0.19
-8.23%
Galectin Therapeutics